NEW YORK, Aug. 21 - Sequenom has 18 busy months ahead of it.

The company today announced plans to acquire privately held Axiom Biotechnologies, which Sequenom said will help its nascent pharma division build some internal biology, assay, and drug-discovery muscle. Sequenom also said it will release a gaggle of new products and updated technology beginning in the third quarter and continuing into 2004.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.